Encouraged by the anti-AChE and Aβ1–42 aggregation inhibitory activity of piperazine–genipin hybrids [61], Silalai et al. prepared genipin–1,2,3-triazole hybrids in search of anti-AD agents. Here, ACHE is linked to Alzheimer disease.